Jarushka Naidoo

Also affiliated with Beaumont Hospital, Food for Health Ireland, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 29 papers. Top paper: “Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer”.

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Journal of Clinical Oncology(2022)10.1200/jco.21.01308

N/A

7.3DataRank · unranked

1324 citations

Corinne Faivre‐Finn, Jhanelle E. Gray, David Vicente, David Planchard, Luis Paz‐Ares +20 more

Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2020.12.015

N/A

6.9DataRank · unranked

471 citations

David Vicente, Takayasu Kurata, David Planchard, Luis Paz‐Ares, Johan Vansteenkiste +18 more

Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002473

N/A

2.5DataRank · unranked

67 citations

Karisa C. Schreck, Wei Fu, Chen Hu, Alexander Carvajal-González, Roisín M. Connolly +18 more

Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study

Journal of Investigative Dermatology(2022)10.1016/j.jid.2022.04.020

N/A

1.8DataRank · unranked

30 citations

Isabelle Brown, Rebecca Goldberg, Matthew T. Taylor, Junwen Deng, Varsha Parthasarathy +15 more

Alliance A151804: Establishment of a national biorepository to advance studies of immune-related adverse events.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3154

N/A

0DataRank · unranked

5 citations

Elad Sharon, Jennifer Le‐Rademacher, Erin Twohy, Tyler Zemla, Yujia Wen +8 more

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Nature(2021)10.1038/s41586-021-03752-4

N/A

0DataRank · unranked

552 citations

Jiajia Zhang, Zhicheng Ji, Ajay Vaghasia, Boyang Zhang, Emily Han-Chung Hsiue +50 more

Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.01.1628

N/A

0DataRank · unranked

129 citations

Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal, Sukhmani K. Padda +11 more

A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4834

N/A

0DataRank · unranked

47 citations

James R. White, Joell J. Gills, Taiki Hakozaki, Corentin Richard, Bertrand Routy +10 more

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100220

N/A

0DataRank · unranked

15 citations

Emily Brigham, Kevin J. Psoter, Khinh Ranh Voong, Bairavi Shankar, David S. Ettinger +16 more

Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management

Cancer Treatment Reviews(2022)10.1016/j.ctrv.2022.102378

N/A

0DataRank · unranked

170 citations

Mizuki Nishino, Lisa Lancaster, Bob T. Li, Andrew G. Nicholson, Brian J. Bartholmai +9 more

Cardiovascular complications of immune checkpoint inhibitors for cancer

European Heart Journal(2022)10.1093/eurheartj/ehac456

N/A

0DataRank · unranked

130 citations

Jarushka Naidoo, Tomas G. Neilan, Franck Thuny

Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03169-6

N/A

0DataRank · unranked

30 citations

Joell J. Gills, Fuad Mohammad, James R. White, Courtney Stevens, Hua Ding +15 more

Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy

The Oncologist(2022)10.1093/oncolo/oyac140

N/A

0DataRank · unranked

20 citations

Joseph C. Murray, Kevin J. Psoter, Jiajia Zhang, Durrant Barasa, Julie R. Brahmer +14 more

Sex-specific differences in immunogenomic features of response to immune checkpoint blockade

Frontiers in Oncology(2022)10.3389/fonc.2022.945798

N/A

0DataRank · unranked

13 citations

Xiaoshan M. Shao, Noushin Niknafs, Archana Balan, Gavin Pereira, Kristen A. Marrone +12 more

Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team

Journal of Cancer Research and Clinical Oncology(2022)10.1007/s00432-022-04299-1

N/A

0DataRank · unranked

11 citations

Ahyoung Kim, Sean Li, Jarushka Naidoo, Laura C. Cappelli, Julie R. Brahmer +3 more

Seq-ing the SINEs of Central Nervous System Tumors in Cerebrospinal Fluid DNA

medRxiv(2022)10.1101/2022.06.28.22276835

N/A

0DataRank · unranked

0 citations

Samuel M. Curtis, Mahmoud Summers, Tej D. Azad, Jordina Rincón-Torroella, Bracha Erlanger Avigdor +33 more

Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1469

N/A

0DataRank · unranked

34 citations

Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James R. White, Noushin Niknafs +28 more

Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101148

N/A

0DataRank · unranked

18 citations

Samuel M. Curtis, Mahmoud Summers, Tej D. Azad, Jordina Rincón-Torroella, Yuxuan Wang +35 more

Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective study

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007188

N/A

0DataRank · unranked

9 citations

Peter B. Illei, Bradley Presson, Dipika Singh, Zhen Zeng, Mara Lanis +12 more

Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.23.546338

N/A

0DataRank · unranked

3 citations

Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James R. White, Noushin Niknafs +25 more

Data from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors

(2023)10.1158/1078-0432.c.6530814

N/A

0DataRank · unranked

0 citations

James R. White, Joell J. Gills, Taiki Hakozaki, Corentin Richard, Bertrand Routy +10 more

Data from A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors

(2023)10.1158/1078-0432.c.6530814.v1

N/A

0DataRank · unranked

0 citations

James R. White, Joell J. Gills, Taiki Hakozaki, Corentin Richard, Bertrand Routy +10 more

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007675

N/A

0DataRank · unranked

27 citations

Yevgeniy R. Semenov, Allireza Alloo, Daniel Q. Bach, Allison Betof Warner, Amina Bougrine +36 more

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures

Journal of Clinical Investigation(2024)10.1172/jci176567

N/A

0DataRank · unranked

26 citations

Soren Charmsaz, Stephanie Alden, Madelena Brancati, Howard L. Li, Aanika Balaji +38 more

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001282

N/A

0DataRank · unranked

166 citations

Valsamo Anagnostou, Tricia R. Cottrell, Kellie N. Smith, Franco Verde, Marianna Zahurak +27 more

Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1788

N/A

0DataRank · unranked

4 citations

Yuxuan Wang, Anita Kalluri, Megan Parker, Joshua D. Cohen, Jonathan C. Dudley +37 more

Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research

The Lancet Oncology(2020)10.1016/s1470-2045(20)30107-8

N/A

0DataRank · unranked

110 citations

Kerry L. Reynolds, Ryan J. Sullivan, Justin M. Balko, James R. Patrinely, Laura C. Cappelli +3 more

Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non–Small-Cell Lung Cancer

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.02.025

N/A

0DataRank · unranked

70 citations

Mizuki Nishino, Sandip Pravin Patel, Bairavi Shankar, Natasha Rekhtman, Peter B. Illei +2 more

A phase Ib study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3158

N/A

0DataRank · unranked

6 citations

María E. Suarez‐Almazor, Jeane Painter, Tanner M. Johanns, Michael Dougan, Laura C. Cappelli +15 more